Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.

about

An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

P2860

Q36400459-85C2CD0E-8106-4475-9DF0-B21F328C25E1 Q55250317-723A4016-BBFA-417B-AFEF-EF7156469194

P2860

Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.

Item

http://www.wikidata.org/entity/Q38569768

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Functionalised particles using ...... very: promises and challenges.

@en

type

Item

label

Functionalised particles using ...... very: promises and challenges.

@en

prefLabel

Functionalised particles using ...... very: promises and challenges.

@en

P1476

Functionalised particles using ...... ivery: promises and challenges

@en

P2093

Eman Z Dahmash

http://www.w3.org/2001/XMLSchema#string

P2860

Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.

Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.

Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.

Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.

The use of ordered mixtures for improving the dissolution rate of low solubility compounds.

Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.

Sampling and characterization of pharmaceutical powders and granular blends.

Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development.

Mechanical methods for dry particle coating processes and their applications in drug delivery and development.

Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.

P304

1867-1879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2015.1071351

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Afzal R Mohammed

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26289674

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.

about

P2860

P2860

Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921